Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization.
Moore
C K
CK
Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, Salt Lake City.
O'Connell
J B
JB
Renlund
D G
DG
Bristow
M R
MR
Hammond
E H
EH
D000911:Antibodies, Monoclonal / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology / Q000379:methods* / Q000473:pathology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3; D009206:Myocardium / Q000473:pathology
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3